This review contains the first European guidance on multiparametric MRI, including cT1, for suspected NAFLD: outlines how to assess fibrosis and inflammation risk and suggests how clinical management and treatment monitoring can be improved.
This review contains the first European guidance on multiparametric MRI, including cT1, for suspected NAFLD: outlines how to assess fibrosis and inflammation risk and suggests how clinical management and treatment monitoring can be improved.